Atara Biotherapeutics, Inc. (ATRA)

Last Closing Price: 12.36 (2025-08-28)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Atara Biotherapeutics, Inc. (ATRA) had Revenue of $17.57M for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
Revenue
$17.57M
$2.39M
$0.55M
$17.02M
$14.38M
$3.20M
$-0.81M
$2.39M
$2.39M
$2.39M
$2.39M
$2.39M
$2.39M
$3.20M
$3.43M
12.20M
12.31M
$0.20
$0.19
Balance Sheet Financials
$24.77M
$0.18M
$12.13M
$36.90M
$14.56M
--
$57.38M
$71.94M
$-35.04M
$-35.04M
$-35.04M
6.98M
Cash Flow Statement Financials
$-35.46M
$12.13M
$15.05M
$25.18M
$16.90M
$-8.27M
$7.01M
--
--
Fundamental Metrics & Ratios
1.70
--
--
--
--
96.85%
18.19%
18.19%
--
13.60%
13.58%
$-35.11M
--
--
--
0.48
--
--
--
-6.81%
-6.81%
6.47%
-6.81%
$-5.02
$-2.85
$-2.88